SynthesisFrontiers in pharmacology2022

Efficacy of immune checkpoint inhibitors in EGFR-Mutant NSCLC patients with EGFR-TKI resistance: A systematic review and meta-analysis.

Xiaoyu Qian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.